Furthermore, to assess the potential role of MCPIP1 in cellular resistance to chemotherapy, we treated PC cells with gemcitabine (Gem), a first‐line therapeutic agent for PC. This evidence concerns the gene ZC3H12A and pachyonychia congenita.